These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6226637)

  • 1. Antibacterial activity of norfloxacin.
    Spencer RC; Wheat P; Smith T
    J Antimicrob Chemother; 1983 Sep; 12(3):291. PubMed ID: 6226637
    [No Abstract]   [Full Text] [Related]  

  • 2. Frequency of appearance of resistant variants to norfloxacin and nalidixic acid.
    Duckworth GJ; Williams JD
    J Antimicrob Chemother; 1984 May; 13 Suppl B():33-8. PubMed ID: 6234273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Belgian multicenter in vitro study of norfloxacin.
    Verbist L
    Acta Clin Belg; 1985; 40(3):167-73. PubMed ID: 3161262
    [No Abstract]   [Full Text] [Related]  

  • 4. The in-vitro activity of ciprofloxacin compared with that of norfloxacin and nalidixic acid.
    King A; Shannon K; Phillips I
    J Antimicrob Chemother; 1984 Apr; 13(4):325-31. PubMed ID: 6233249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro effect of pH and glucose concentration on the antibacterial activity of norfloxacin in urine.
    Fromtling RA; Abruzzo GK; Gadebusch HH
    Methods Find Exp Clin Pharmacol; 1984 Dec; 6(12):737-41. PubMed ID: 6241649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Norfloxacin--a new antibacterial agent with anti-pseudomonal activity.
    Peddie BA
    N Z Med J; 1982 Oct; 95(717):712. PubMed ID: 6216426
    [No Abstract]   [Full Text] [Related]  

  • 7. In-vitro activity of enoxacin, ofloxacin, norfloxacin and nalidixic acid.
    Bauernfeind A; Ullmann U
    J Antimicrob Chemother; 1984 Sep; 14 Suppl C():33-8. PubMed ID: 6238931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro antibacterial action of norfloxacin].
    Fabio U; Provvisionato CA; Tampieri A; Quaglio GP
    G Ital Chemioter; 1983; 30(1):53-9. PubMed ID: 6229443
    [No Abstract]   [Full Text] [Related]  

  • 9. Norfloxacin and the antibacterial gamma pyridone beta carboxylic acids.
    Newsom SW; Matthews J; Amphlett M; Warren RE
    J Antimicrob Chemother; 1982 Jul; 10(1):25-30. PubMed ID: 6213593
    [No Abstract]   [Full Text] [Related]  

  • 10. Norfloxacin: activity against urinary tract pathogens and factors influencing the emergence of resistance.
    Greenwood D; Osman M; Goodwin J; Cowlishaw WA; Slack R
    J Antimicrob Chemother; 1984 Apr; 13(4):315-23. PubMed ID: 6233248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigations into the mechanism of action of the antibacterial agent norfloxacin.
    Crumplin GC; Kenwright M; Hirst T
    J Antimicrob Chemother; 1984 May; 13 Suppl B():9-23. PubMed ID: 6203890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory evaluation of enoxacin: comparison with norfloxacin and nalidixic acid.
    Teoh-Chan CH; Cowlishaw A; Eley A; Slater G; Greenwood D
    J Antimicrob Chemother; 1985 Jan; 15(1):45-52. PubMed ID: 3156113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The comparative activity of norfloxacin with other antimicrobial agents against Gram-positive and Gram-negative bacteria.
    Corrado ML; Cherubin CE; Shulman M
    J Antimicrob Chemother; 1983 Apr; 11(4):369-76. PubMed ID: 6222023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro emergence of Escherichia coli and Pseudomonas aeruginosa strains resistant to norfloxacin and nalidixic acid.
    Piffaretti JC; Demarta A; Leidi-Bulla L; Peduzzi R
    Eur J Clin Microbiol; 1983 Dec; 2(6):600-1. PubMed ID: 6230227
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibacterial activity of norfloxacin in the gastrointestinal tracts of rats.
    Frimodt-Møller PC; Jensen KM; Madsen PO
    Antimicrob Agents Chemother; 1983 Oct; 24(4):560-3. PubMed ID: 6228191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of norfloxacin in synthetic media and human urine compared to that of cinnoxacin, nalidixic acid and pipemidic acid.
    Shah PM; Ottnad-Walz M; Stille W
    Methods Find Exp Clin Pharmacol; 1983 Dec; 5(10):731-4. PubMed ID: 6231438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative in-vitro activity of norfloxacin and selected antimicrobial agents against urinary tract pathogens and Neisseria gonorrhoeae.
    Sweet RL; Ohm-Smith MJ; Hadley WK
    J Antimicrob Chemother; 1982 Dec; 10(6):553-7. PubMed ID: 6219085
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibacterial efficacy of norfloxacin, trimethoprim-sulfamethoxazole, and gentamicin in experimentally-infected normal and streptozotocin-induced diabetic mice.
    Fromtling RA; Abruzzo GK; Gadebusch HH
    Methods Find Exp Clin Pharmacol; 1984 Dec; 6(12):731-5. PubMed ID: 6241648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antimicrobial spectrum of norfloxacin.
    Newsom SW
    J Antimicrob Chemother; 1984 May; 13 Suppl B():25-31. PubMed ID: 6234272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro antibacterial activity of norfloxacin and other agents against ocular pathogens.
    Shungu DL; Tutlane VK; Weinberg E; Gadebusch HH
    Chemotherapy; 1985; 31(2):112-8. PubMed ID: 3157551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.